Moderna, Inc.
MRNABiotechnology
$222.76+4.01%As of Oct 29vs prior close
- Market cap
- $88.9B
- P/E (TTM)
- –
- From 52W high
- −9.38%
- EPS (LTM)
- -$7.98
- Revenue (LTM)
- $2.2B
- Net margin
- -141.43%
Nomior Score
55
Steady ProfileSpeculativeTop 37% of the scored universe
Growth48
Quality40
Value53
Momentum99
Resilience29
Growth
+37.82%revenue a year over 9 fiscal years
YE16 $108.4MLTM $2.2B
Connections
Revenue to profitQ2 YE26
The operating loss was 562% of revenue, narrower by 77 pts on a year.
Who owns it
5funds